Analysis of the Global Growth in Breast Biopsy Market Mar-2017

Global Breast Biopsy Market 2017-2021
The Breast Biopsy market report contains a comprehensive market and vendor landscape in addition to
a SWOT analysis of the key vendors for 2017-2021. The following companies are the key players in the
global breast biopsy market: BD, C.R. Bard, Hologic, and Leica Biosystems. Other Prominent Vendors in
the market are Argon Medical Devices, Aurora Imaging, Biopsybell, Bracco Imaging, Carestream Health,
Cook Medical, Fischer Medical Technologies, Imaging Equipment, Intact Medical, Internazionale Medico
Scientifica, Metaltronica, NuVue Therapeutics, PerkinElmer, Planmed OY, Sectra, STERYLAB, Terason,
and ZAMAR CARE.
For More Information Inquire @
http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=929092
Market Trend
The latest trend gaining momentum in the breast biopsy market is increase in reimbursement for breast
biopsy. The rise in the number of breast biopsy procedures in the last few years has seen a
corresponding increase in reimbursement for breast biopsies. Most of the medical healthcare facilities
such as the Centers for Medicare & Medicaid Services (CMS) had fixed payment for bundled breast
biopsy devices in 2015. This has leveraged the reimbursement to hospitals by 51% compared with 2014
rates.
Market Driver
One of the major drivers for breast biopsy market is growing incidence of breast cancer. The rising
incidence of breast cancer is fueling the growth of the breast biopsy market worldwide. Breast cancer is
the most common cancer prevalent in females and is the second most common cancer overall, after skin
cancer. Breast cancer is found to affect men above 50 years of age and is rare in young women.
Market Challenge
One of the major factors hindering the growth of breast biopsy market is complications and risks
associated with breast biopsies. In several reported cases, breast needles biopsies have been known to
cause significant complications in patients. The faulty execution of biopsies can cause damage to nearby
tissues or organs, as well as skin numbness around the biopsy site. Bruising, infection, mild pain, and
prolonged bleeding from the target site are the most common risks during the procedure. The risk of
bleeding results in the formation of hematoma during the collection of blood at the biopsy site;
however, the risk is seen in less than 1% of the patients. Any surgical procedure, invasive or less
invasive, carries risks. The chances of infections are less when performed with antibiotics.
Purchase Report Directly @ http://www.reportsnreports.com/purchase.aspx?name=929092
Table of Contents of the Report
PART 01: Executive summary
PART 02: Scope of the report